1,520 Alzheimers Headlines
Patricio Reyes M.D., F.A.N.N.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

Barrow Neurological Institute
St. Joseph's Hospital and Medical Center
"2 NEW THERAPIES FOR ALZHEIMER'S"
Produced by MD Health Channel
Executive Editor.....Anne-Merete Robbs
CEO..............Stan Swartz

Dr. Reyes and his team are constantly working on new medicines and new solutions...You will receive news alerts...information on new trials as Dr Reyes announces them!
"2 NEW THERAPIES FOR ALZHEIMER'S"
Patricio Reyes M.D., F.A.N.N.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

St. Joseph's Hospital and Medical Center



DO YOU HAVE ALZHEIMERS?
 
"HELP DR. REYES... IN HIS BATTLE TO FIND A CURE...
.HE NEEDS YOUR HELP:
YOU CAN HELP WIN THE BATTLE FOR A CURE BY JOINING A TRIAL!!"....

Stan Swartz, CEO,
The MD Health Channel



"You'll receive all medication and study based procedures at
no charge

if you qualify for one of the many trials being conducted at Barrow Neurological Institute."
 

"Dr. Reyes Changed My Life"

- John Swartz
92 Years Old
Attorney at Law
"Dr.Reyes Changed My Life "
1:18
"At 92...I had lost my will to live"
5:48
Tips on Aging
2:29
"Dr. Reyes gave me customized health care"
2:09

Patricio Reyes M.D.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

Barrow Neurological Institute

St. Joseph's Hospital and Medical Center
"PRESERVING BRAIN FUNCTIONS "
Runtime: 50:22
Runtime: 50:22
"2 NEW THERAPIES FOR ALZHEIMER'S"
Runtime: 10:27
Runtime: 10:27
ALZHEIMER'S AWARENESS PROGRAMS
Runtime: 5:00
Runtime: 5:00
BIOMEDICAL RESEARCH IN ALZHEIMER'S DISEASE
PDF Document 850 kb

Download Free

4 TALES OF NEUROSURGERY &
A PIANO CONCERT BY DR. SPETZLER...
Plus 2 books written by Survivors for Survivors!
Robert F. Spetzler M.D.
Director, Barrow Neurological Institute

J.N. Harber Chairman of Neurological Surgery

Professor Section of Neurosurgery
University of Arizona
TALES OF NEUROSURGERY:
A pregnant mother..a baby..faith of a husband.. .plus... Cardiac Standstill: cooling the patient to 15 degrees Centigrade!
Lou Grubb Anurism
The young Heros - kids who are confronted with significant medical problems!
2 Patients...confronted with enormous decisions before their surgery...wrote these books to help others!
A 1 MINUTE PIANO CONCERT BY DR. SPETZLER

Michele M. Grigaitis MS, NP
Alzheimer's Disease and Cognitive Disorders Clinic

Barrow Neurological Clinics
COPING WITH DEMENTIA
 
Free Windows Media Player Click

Links
Barrow Neurological Institute

Archives
October 2006  
November 2006  
December 2006  
January 2007  
February 2007  
March 2007  
May 2007  
June 2007  
November 2007  
December 2007  
April 2008  
July 2008  
August 2008  
September 2008  
October 2008  
November 2008  
December 2008  
January 2009  
February 2009  
March 2009  
April 2009  
May 2009  
February 2010  
March 2013  
May 2013  
November 2013  
January 2014  
February 2014  
March 2014  
April 2014  
May 2014  
June 2014  
July 2014  
June 2016  
July 2016  
August 2016  
September 2016  
October 2016  
November 2016  
December 2016  
January 2017  
February 2017  
March 2017  
April 2017  
May 2017  
June 2017  
July 2017  
August 2017  
September 2017  
October 2017  
November 2017  
December 2017  
January 2018  
February 2018  
March 2018  
April 2018  
May 2018  

This page is powered by Blogger. Isn't yours?

Saturday, October 29, 2016

 

Cardio Stress Response Reduced in Preclinical Alzheimer's















Patients in the earliest stages of Alzheimer's disease show significant decreases in cardiovascular response to stress compared with those who don't have the disease, new research suggests.

"To our knowledge, this is the first time that such an observation has been made — specifically — in older adults who are known to be within the preclinical stage of Alzheimer's disease," senior author Peter J. Snyder, PhD, told Medscape Medical News.

"The findings show that, even in the earliest preclinical stage of the disease, there are subtle effects on peripheral cardiac control," said Dr Snyder, who is a professor of neurology at Alpert Medical School of Brown University and senior vice president and chief research officer of the Lifespan Hospital System, Providence, Rhode Island.

Their findings were presented here at the American Neurological Association (ANA) 2016 Annual Meeting.

The study involved 63 adults, with a mean age of 62 years (range, 55 - 75 years), who were determined to have preclinical Alzheimer's disease, with a self-reported first-degree family history of the disease, reports of memory problems, and positron emission tomography findings indicating elevated cortical burden of β-amyloid, a pathological hallmark of Alzheimer's disease.

The patients were evaluated with electrocardiography for changes in vagal tone at rest and then during performance on the Groton Maze Learning Test, a computer-administered hidden maze learning test designed to induce mild cognitive stress for approximately 190 seconds.

Measures evaluated at baseline and 18-month follow-ups included respiratory sinus arrhythmia (RSA) and heart rate variability (HRV).

The results showed that patients who did not have preclinical Alzheimer's disease (β-amyloid negative) had normal vagal ratios, with normal increases in HRV while exposed to cognitive stress (P = .0061) and subsequent decreases at rest (P < .0001).

Similar responses were observed with RSA — the β-amyloid–negative patients showed increases while exposed to cognitive stress in relation to the pre- and post-stress conditions (P < .0001).

In contrast, the β-amyloid–positive patients failed to show alterations in HRV or RSA in response to cognitive stress at any point during the testing.

"β-Amyloid–positive subjects showed no change in RSA at any point during testing," the authors said.

"Not only were [the β-amyloid–positive patients'] responses less than those of patients without elevated β-amyloid, but they were so dampened as to fail to be statistically significantly different from either pre- or post-test," they added.

"Both measures were expected to show modest increases, reflecting heightened autonomic arousal, during completion of a neuropsychological test."

The vagal ratio between high- and low-frequency components of HRV and RSA typically becomes less reactive with normal aging as the result of declines in parasympathetic tone; however, the greater changes in early Alzheimer's are notable, the authors explained.

In a previous study published in the Journal of Alzheimer's Disease, they found evidence of increases in resting cardiac workload among patients with preclinical Alzheimer's disease.

The changes in vagal tone observed in the new study may be indicators of the changes slowly taking place in the brain during early-stage Alzheimer's disease, Dr Snyder speculated.

"We believe that this may suggest that patients in the preclinical stage of the disease are experiencing prodromal changes in the brain's control of autonomic functions, most likely impacting vagal control of the heart," he said.

Much more needs to be understood about the relationship, he added.

"These findings point to a complex relationship between Alzheimer's disease and the autonomic nervous system's control of the heart," Dr Snyder said.


Story Source: The above story is based on materials provided by MEDSCAPE
Note: Materials may be edited for content and length